Siyuan Zhao
Shanghai, 200137, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "iRGD-modified peptide-drug conjugate improves brain delivery and antitumor efficacy in glioblastoma" [European Journal of Pharmaceutical Sciences 224 (2026) 107599].
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: July 25, 2026
iRGD-Modified Peptide-Drug Conjugate Improves Brain Delivery and Antitumor Efficacy in Glioblastoma.
iRGD-Modified Peptide-Drug Conjugate Improves Brain Delivery and Antitumor Efficacy in Glioblastoma.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 03, 2026
Biomimetic membrane-coated metal nanoplatforms for enhanced BBB penetration and targeted glioblastoma therapy.
Journal: International journal of pharmaceutics: X
Published: May 31, 2026
Anthraquinone-Loaded Liposomes for TAM Reprogramming in Triple-Negative Breast Cancer: Mechanistic Rationale, Delivery Logic, and Translational Challenges.
Journal: Pharmaceutics
Published: April 07, 2026
A novel bicyclic peptide-drug conjugate of 3-fluoro-10-hydroxy-evodiamine for targeted colorectal cancer therapy.
Journal: Journal of pharmaceutical sciences
Published: November 16, 2025
Peptide-drug conjugates: Emerging strategies in glioma therapy.
Journal: Bioorganic chemistry
Published: July 31, 2025
5-Fluorouracil-methotrexate conjugate enhances the efficacy of 5-fluorouracil in colorectal cancer therapy.
Journal: Investigational new drugs
Published: October 21, 2024
Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.
Journal: Pharmacological research
Published: June 12, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026